Directory › PolyPeptide

PolyPeptide — Torrance

Torrance, California, United States · CDMO

This is a record of what regulators published, not a rating.

Site facts

Company
PolyPeptide
Name(s) in FDA data
PolyPeptide Laboratories, Inc.
FEI number(s)
1000519239 (present in FDA Data Dashboard records for this name and city)
Location (as in FDA data)
Torrance, California, United States 90503
Records matched
10 FDA inspections
Most recent FDA inspection in dataset
10 May 2024 — VAI

Capabilities (from the company's website)

  • Lyophilization
    …intermediary processing laboratories, 7 purification suites, and several large scale tray lyophilization units. A state of the art QC lab has been established to support development and com…
  • API / drug substance (chemical)
    …he US FDA and other international regulatory bodies with approvals for over 10 commercial Active Pharmaceutical Ingredients. PolyPeptide San Diego, USA The San Diego, California site is a 45,000 square foot facil…
  • Oral liquids & semi-solids
    …peptides in milligram to gram quantities. The facility can also support production of isotopically labeled and radio-labeled peptides. The San Diego facility has been successfully inspec…
  • Peptides & oligonucleotides
    …PolyPeptide Torrance, USA The Torrance, California site is a 120,000 square foot (~12,000 sq. meters)…
  • Formulation & process development
    …s an area dedicated to development activities primarily to support GMP production through process development and process optimization. For GMP manufacturing, this facility supports 5 solid phase syn…

Taken from the company's web page for this site. Source: https://www.polypeptide.com/contacts/manufacturing-sites/san-diego-and-torrance-usa/, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.

Regulatory timeline

Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.

  1. 10 May 2024
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs, Veterinary. Project area(s): Drug Quality Assurance; Monitoring of Marketed Animal Drugs, Feed, and Devices.

    Source: FDA Data Dashboard – Inspections (FEI 1000519239, inspection ID 1246171)

  2. 19 Nov 2021
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs, Veterinary. Project area(s): Drug Quality Assurance; Monitoring of Marketed Animal Drugs, Feed, and Devices.

    Source: FDA Data Dashboard – Inspections (FEI 1000519239, inspection ID 1159374)

  3. 30 Aug 2019
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Veterinary. Project area(s): Monitoring of Marketed Animal Drugs, Feed, and Devices.

    Source: FDA Data Dashboard – Inspections (FEI 1000519239, inspection ID 1103072)

  4. 19 Jul 2017
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs, Veterinary. Project area(s): Drug Quality Assurance; Monitoring of Marketed Animal Drugs, Feed, and Devices.

    Source: FDA Data Dashboard – Inspections (FEI 1000519239, inspection ID 1021060)

  5. 03 Dec 2015
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs, Veterinary. Project area(s): Drug Quality Assurance; Monitoring of Marketed Animal Drugs, Feed, and Devices.

    Source: FDA Data Dashboard – Inspections (FEI 1000519239, inspection ID 953881)

  6. 12 Apr 2013
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs, Veterinary. Project area(s): Drug Quality Assurance; Monitoring of Marketed Animal Drugs, Feed, and Devices.

    Source: FDA Data Dashboard – Inspections (FEI 1000519239, inspection ID 827287)

  7. 22 Feb 2012
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 1000519239, inspection ID 770485)

  8. 07 Jul 2011
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs, Veterinary. Project area(s): Drug Quality Assurance; Monitoring of Marketed Animal Drugs, Feed, and Devices.

    Source: FDA Data Dashboard – Inspections (FEI 1000519239, inspection ID 732994)

  9. 13 Jan 2010
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs, Veterinary. Project area(s): Drug Quality Assurance; Monitoring of Marketed Animal Drugs, Feed, and Devices.

    Source: FDA Data Dashboard – Inspections (FEI 1000519239, inspection ID 638781)

  10. 27 Mar 2009
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs, Veterinary. Project area(s): Drug Quality Assurance; Monitoring of Marketed Animal Drugs, Feed, and Devices.

    Source: FDA Data Dashboard – Inspections (FEI 1000519239, inspection ID 573000)

This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.